Eisai
4523.T
#2216
Rank
โ‚น851.39 B
Marketcap
โ‚น3,017
Share price
-0.46%
Change (1 day)
-1.86%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น83.05. In 2026 the company made an earnings per share (EPS) of โ‚น82.69 a decrease over its 2025 EPS that were of โ‚น104.72.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026โ‚น82.69-21.04%
2025โ‚น104.7211.85%
2024โ‚น93.62-32.63%
2023โ‚น138.975.52%
2022โ‚น131.70-74.01%
2021โ‚น506.68-66.58%
2020โ‚น1,51698.24%
2019โ‚น764.6617.01%
2018โ‚น653.4937.78%
2017โ‚น474.31-27.62%
2016โ‚น655.3335.33%
2015โ‚น484.24-2.82%
2014โ‚น498.31-27.66%
2013โ‚น688.88-27.49%
2012โ‚น950.09-12.67%
2011โ‚น1,08888.08%
2010โ‚น578.47-11.06%
2009โ‚น650.42-390.15%
2008-โ‚น224.17-127.78%
2007โ‚น807.05347.11%
2006โ‚น180.504.38%
2005โ‚น172.947.4%
2004โ‚น161.0343.03%
2003โ‚น112.5925.09%
2002โ‚น90.0052.67%
2001โ‚น58.9569.76%
2000โ‚น34.73